ZIOPHARM Oncology
ZIOPHARM Oncology
Employees:
40
Market Cap:
$655.72 million
Revenue:
$6.2 million
5 Year Trend:
51.5%
Net Income:
$-91.5 million
Stock:
ZIOP

ZIOPHARM Oncology is a publicly held, clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, that develops novel immunotherapies for the treatment of cancer. In 2011, ZIOPHARM established a partnership with Intrexon Corporation to develop and commercialize DNA-based cancer drugs based on Intrexons synthetic biology technology platform. Wikipedia

ZIOPHARM Oncology
Are you from ZIOPHARM Oncology?

ZIOPHARM Oncology is a publicly held, clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, that develops novel immunotherapies for the treatment of cancer. In 2011, ZIOPHARM established a partnership with Intrexon Corporation to develop and commercialize DNA-based cancer drugs based on Intrexons synthetic biology technology platform. Wikipedia

Employees:
40
Market Cap:
$655.72 million
Revenue:
$6.2 million
5 Year Trend:
51.5%
Net Income:
$-91.5 million
Stock:
ZIOP

Jobs at at ZIOPHARM Oncology

There are no jobs at the current time